These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24240729)

  • 1. Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.
    Sequeira V; Witjas-Paalberends ER; Kuster DW; van der Velden J
    Pflugers Arch; 2014 Feb; 466(2):201-6. PubMed ID: 24240729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability.
    Smelter DF; de Lange WJ; Cai W; Ge Y; Ralphe JC
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1179-H1191. PubMed ID: 29451820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
    Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
    J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.
    Barefield D; Kumar M; de Tombe PP; Sadayappan S
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H807-15. PubMed ID: 24464755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
    Mun JY; Kensler RW; Harris SP; Craig R
    J Mol Cell Cardiol; 2016 Feb; 91():141-7. PubMed ID: 26718724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
    de Lange WJ; Grimes AC; Hegge LF; Ralphe JC
    J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
    Parbhudayal RY; Garra AR; Götte MJW; Michels M; Pei J; Harakalova M; Asselbergs FW; van Rossum AC; van der Velden J; Kuster DWD
    J Mol Cell Cardiol; 2018 Oct; 123():59-63. PubMed ID: 30170119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.
    Mamidi R; Li J; Gresham KS; Stelzer JE
    Pflugers Arch; 2014 Feb; 466(2):225-30. PubMed ID: 24310821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.
    Barefield D; Kumar M; Gorham J; Seidman JG; Seidman CE; de Tombe PP; Sadayappan S
    J Mol Cell Cardiol; 2015 Feb; 79():234-43. PubMed ID: 25463273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.
    Bhuiyan MS; McLendon P; James J; Osinska H; Gulick J; Bhandary B; Lorenz JN; Robbins J
    Pflugers Arch; 2016 Oct; 468(10):1685-95. PubMed ID: 27568194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
    McNamara JW; Li A; Lal S; Bos JM; Harris SP; van der Velden J; Ackerman MJ; Cooke R; Dos Remedios CG
    PLoS One; 2017; 12(6):e0180064. PubMed ID: 28658286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP-C.
    Suay-Corredera C; Alegre-Cebollada J
    FEBS Lett; 2022 Mar; 596(6):703-746. PubMed ID: 35224729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.
    van Dijk SJ; Bezold Kooiker K; Mazzalupo S; Yang Y; Kostyukova AS; Mustacich DJ; Hoye ER; Stern JA; Kittleson MD; Harris SP
    Arch Biochem Biophys; 2016 Jul; 601():133-40. PubMed ID: 26777460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the critical residues responsible for cardiac myosin binding protein C's interactions.
    Bhuiyan MS; Gulick J; Osinska H; Gupta M; Robbins J
    J Mol Cell Cardiol; 2012 Dec; 53(6):838-47. PubMed ID: 22982234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy mutations in
    Toepfer CN; Wakimoto H; Garfinkel AC; McDonough B; Liao D; Jiang J; Tai AC; Gorham JM; Lunde IG; Lun M; Lynch TL; McNamara JW; Sadayappan S; Redwood CS; Watkins HC; Seidman JG; Seidman CE
    Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue.
    Dutsch A; Wijnker PJM; Schlossarek S; Friedrich FW; Krämer E; Braren I; Hirt MN; Brenière-Letuffe D; Rhoden A; Mannhardt I; Eschenhagen T; Carrier L; Mearini G
    Sci Rep; 2019 Dec; 9(1):18152. PubMed ID: 31796859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.